(Q51587900)
Statements
Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension. (English)
1 reference
DeFronzo RA
1 reference
Giordano M
1 reference
Matsuda M
1 reference
Sanders L
1 reference
Canessa ML
1 reference
1 June 1995
1 reference
44
1 reference
6
1 reference
665-671
1 reference